Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business dayGet my quote

Melanoma (skin cancer): US-approved treatments and how Gulf families can access them

Creator: Reserve Meds
Published: 2026-10-17

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Melanoma: the short answer

The US FDA has approved nine medicines on this page for melanoma, each for specific patients. Seven of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

US FDA-approved medicines on this page: Opdivo, Keytruda, Opdualag, Braftovi, Mektovi, Tafinlar, Mekinist, Amtagvi and Kimmtrak.
Gulf registration (checked 17 October 2026): see each medicine below.
Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital; cell and gene therapies at a qualified center.
Price: Quote on request.

What is melanoma?

Melanoma is the most serious type of skin cancer. Often the first sign is a change in the size, shape, color or feel of a mole, or a new mole that looks unusual. Doctors use the ABCDE checklist: asymmetry, irregular border, uneven color, change in diameter, and a mole that is evolving.^[1]

Surgery is the first treatment for all stages of melanoma. Other options include chemotherapy, radiation, biologic therapy that boosts the body's own ability to fight cancer, and targeted therapy that attacks cancer cells with less harm to normal cells.^[1]

For melanoma that has spread or cannot be removed, US-approved options include immunotherapy and, for tumors with a BRAF V600 mutation, combinations of targeted tablets. A tumor-derived cell therapy is approved for some patients after earlier treatments. A separate medicine is approved for a rare eye melanoma called uveal melanoma.^{[2, 3, 4, 5]}

Melanoma in the Gulf

A review of skin cancer cases diagnosed in Taif, Saudi Arabia, between 2011 and 2022 found 91 skin cancers, of which only 4 were invasive melanoma. Squamous cell and basal cell carcinoma were far more common. Published Gulf data on melanoma remain limited.^[6]

US FDA-approved medicines for melanoma

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

Opdivo (nivolumab)
FDA-approved for adults and children 12 years and older with melanoma that cannot be removed or has spread, alone or with ipilimumab, and after complete surgery for stage IIB to IV melanoma (adjuvant treatment). It is given by intravenous infusion.^[2]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Keytruda (pembrolizumab)
FDA-approved for patients with melanoma that cannot be removed or has spread, and as adjuvant treatment after complete surgery for stage IIB, IIC or III melanoma in adults and children 12 years and older. It is given by intravenous infusion.^[9]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, Lebanon, Iraq, Turkey, India, Pakistan
Opdualag (nivolumab and relatlimab-rmbw)
FDA-approved for adults and children 12 years and older with melanoma that cannot be removed or has spread. It combines nivolumab and relatlimab in one infusion.^[10]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Braftovi (encorafenib)
FDA-approved for melanoma that cannot be removed or has spread when the tumor has a BRAF V600E or V600K mutation, in combination with binimetinib (Mektovi). It is a capsule.^[3]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman
Mektovi (binimetinib)
FDA-approved for melanoma that cannot be removed or has spread with a BRAF V600E or V600K mutation, in combination with encorafenib (Braftovi). It is a tablet.^[11]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt
Tafinlar (dabrafenib)
FDA-approved for melanoma with a BRAF V600E mutation that cannot be removed or has spread, and, together with trametinib (Mekinist), BRAF V600E or V600K melanoma that has spread or, after complete surgery, has reached the lymph nodes. It is taken by mouth.^[12]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan
Mekinist (trametinib)
FDA-approved for BRAF V600E or V600K melanoma that cannot be removed or has spread, alone in patients not treated with a BRAF inhibitor or together with dabrafenib (Tafinlar), and with dabrafenib after complete surgery when lymph nodes are involved. It is a tablet.^[13]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman
Amtagvi (lifileucel)
FDA-approved for adults with melanoma that cannot be removed or has spread after a PD-1 blocking antibody and, if the tumor has a BRAF V600 mutation, after a BRAF inhibitor with or without a MEK inhibitor. It is made from the patient's own tumor cells and given once by infusion at a specialized center. Approved under accelerated approval.^[4]
Given at a qualified treatment center. Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Jordan, Pakistan
Kimmtrak (tebentafusp)
FDA-approved for adults with uveal melanoma (melanoma of the eye) that cannot be removed or has spread, when the patient is HLA-A*02:01-positive. It is given by intravenous infusion.^[5]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.^{[14, 15]} Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

For Amtagvi. These treatments are made for each patient or need a specialized procedure, so treatment happens at a qualified center. For most Gulf families that means a referral from the treating specialist to a center that can give the treatment. A local hospital can only give it if the manufacturer agrees to supply that hospital and the regulator approves. We cannot promise that a manufacturer will agree.

Who does what

Your treating specialist decides whether a medicine is right for the patient and writes the letter.
The hospital checks local supply, files any import request, and gives the treatment safely.
The national regulator decides whether to approve the import of a medicine that is not registered.
The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
Recent clinic notes and a list of current medicines
For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for melanoma

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

Is there an FDA-approved treatment for melanoma?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Opdivo, Keytruda, Opdualag, Braftovi, Mektovi, Tafinlar, Mekinist, Amtagvi and Kimmtrak. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Opdivo available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Opdivo?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Do I need a gene test before targeted tablets?

Yes. The US labels for the BRAF and MEK tablet combinations require a BRAF V600E or V600K mutation confirmed by an approved test. Your oncologist orders this test on the tumor sample.

What should I watch for on my skin?

MedlinePlus suggests the ABCDE checklist: asymmetry, ragged border, uneven color, a change in size, and a mole that is changing. See a doctor about any new or changing mole.

Sources for the last two answers: ^{[3, 12]} ^[1]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

This page is general health information, not medical advice. It does not replace a consultation with your doctor.